A PROSPECTIVE, COMPARATIVE ANALYSIS OF POST-OPERATIVE HEMOGLOBIN LEVELS: MONOPOLAR VS. BIPOLAR TRANSURETHRAL RESECTION OF PROSTATE FOR MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA

Main Article Content

Muhammad Talha Aizaz
Shahjehan
Hassan Raza Asghar
Ghulam Ghous
Asma Rizwan
Umar Hanif

Keywords

Benign prostatic hyperplasia, Monopolar transurethral, Bipolar transurethral

Abstract

Background: Monopolar transurethral resection of the prostate (M-TURP) has long been considered the gold standard in benign prostate hyperplasia management, however, recently, bipolar transurethral resection of the prostate (B-TURP) has emerged as a new modality, offering potential advantages including the use of isotonic saline as an irrigant. This study aims to compare the post-operative mean hemoglobin levels in patients undergoing M-TURP versus B-TURP in the surgical management of BPH.


Methods: A prospective comparative study was conducted at the Department of Urology in a tertiary hospital over a period from September 2, 2022, to March 2, 2023. Patients were consecutively allocated to either Group M (undergoing M-TURP) or Group B (undergoing B-TURP). Blood specimens were collected 24 hours after surgery to estimate hemoglobin levels post-operatively


Results: The study comprised 136 patients, with Group A (M-TURP) exhibiting a mean age of 62.32±1.79 years and Group B (B-TURP) a mean age of 62.98±1.90 years. Prostate size did not significantly differ between the two groups (p=0.421). However, pre-operative hemoglobin levels were significantly higher in Group B (12.26±0.13 g/dl) compared to Group A (12.29±0.13 g/dl) (p=0.000). Post-operatively, Group B maintained higher mean hemoglobin levels (11.82±0.06 g/dl) compared to Group A (11.19±0.09 g/dl) (p=0.000)


Conclusion: These findings suggest a potential advantage of B-TURP over M-TURP in preserving post-operative hemoglobin levels, highlighting its potential as a preferred surgical modality for BPH management.

Abstract 82 | Pdf Downloads 36

References

1. Madersbacher S, Sampson N, Culig Z. Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: a mini-review. Gerontology. 2019;65(5):458-464. https://doi.org/10.1159/000496289
2. Shabbir A, Khan UT, Nisar D, Rath PK, Kumari C, Zehra T, et al. Frequency and trends of prostatic diseases in a subset of Karachi population: A retrospective study. PJMD. 2021;10(1):17-23. https://doi.org/10.36283/PJMD10-1/004
3. Lokeshwar SD, Harper BT, Webb E, Jordan A, Dykes TA, Neal Jr DE, et al. Epidemiology and treatment modalities for the management of benign prostatic hyperplasia. TAU. 2019;8(5):529. doi: 10.21037/tau.2019.10.01
4. Li H, Zhao C, Liu P, Hu J, Yi Z, Chen J, et al. Radical prostatectomy after previous transurethral resection of the prostate: a systematic review and meta-analysis. TAU. 2019;8(6):712. doi: 10.21037/tau.2019.11.13
5. Alexander CE, Scullion MM, Omar MI, Yuan Y, Mamoulakis C, N'Dow JM, et al. Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction. CDSR. 2019(12). https://doi.org/10.1002/14651858.CD009629.pub4
6. Raghuvanshi K, Raval A, Jain DK, Vartak KP, Patil S, Iqbal S, et al. Comparative assessment of monopolar versus bipolar transurethral resection of prostate for the management of benign prostatic enlargement. Urol Sci. 2019;30(6):262-265.
7. Regmi P, Basnet RB. Outcome of Monopolar versus Bipolar Transurethral Resection of Prostate. JKISTMC. 2024;6(11):20-25. https://doi.org/10.61122/jkistmc279
8. Srinivasrao P, Shashidhar M. Bipolar versus monopolar transurethral resection for benign prostatic hypertrophy: a prospective comparative study. Int Surg J . 2022;9(5):1016-1018. https://doi.org/10.18203/2349-2902.isj20221035
9. Gomes CM, Moromizato JK, Brandão TB. Bipolar and monopolar transurethral resection of the prostate are equally effective and safe in this high quality randomized controled trial. Int Braz J Urol. 2020;47:145-148. https://doi.org/10.1590/S1677-5538.IBJU.2019.0766.1
10. Nasirov PR. Comparative evaluation of monopolar and bipolar transurethral resection of the prostate. Астраханский медицинский журнал. 2019;14(2):81-86.
11. Bruce A, Krishan A, Sadiq S, Ehsanullah SA, Khashaba S. Safety and efficacy of bipolar transurethral resection of the prostate vs monopolar transurethral resection of prostate in the treatment of moderate-large volume prostatic hyperplasia: a systematic review and meta-analysis. J Endourol. 2021;35(5):663-673. https://doi.org/10.1089/end.2020.0840
12. Otaola-Arca H, Álvarez-Ardura M, Molina-Escudero R, Fernández MI, Páez-Borda Á. A prospective randomized study comparing bipolar plasmakinetic transurethral resection of the prostate and monopolar transurethral resection of the prostate for the treatment of Benign Prostatic Hyperplasia: efficacy, sexual function, Quality of Life, and complications. Int Braz J Urol. 2020;47:131-144. https://doi.org/10.1590/S1677-5538.IBJU.2019.0766
13. El-Assmy A, ElShal AM, Mekkawy R, El-Kappany H, Ibrahiem EHI. Erectile and ejaculatory functions changes following bipolar versus monopolar transurethral resection of the prostate: a prospective randomized study. Int Urol Nephrol. 2018;50:1569-1576. https://doi.org/10.1007/s11255-018-1950-6
14. Xie K, Cao D, Wei Q, Ren Z, Li J, Li Y, et al. Bipolar versus monopolar transurethral resection of non-muscle-invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trials. World J Urol. 2021;39:1177-1186. https://doi.org/10.1007/s00345-020-03271-3
15. Huang S-W, Tsai C-Y, Tseng C-S, Shih M-C, Yeh Y-C, Chien K-L, et al. Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: systematic review and network meta-analysis. BMJ. 2019;367. https://doi.org/10.1136/bmj.l5919
16. Rojo E. Comparison of monopolar versus bipolar transurethral resection of the prostate: Evaluation of the impact on sexual function. Revista Internacional de Andrologia. 2019;18(2):43-49. https://doi.org/10.1016/j.androl.2018.07.008